Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis

Stopped Closed after complete treatment of 32 patients after 21 months' recruitment.

Conditions

• Myasthenia Gravis

Interventions

• DRUG: Placebo
• DRUG: 250 mg CK-2017357
• DRUG: 500 mg CK-2017357

Sponsor

Cytokinetics

Collaborators

• [object Object]